Document Type

Patent

Publication Date

2-28-2017

Abstract

Methods of delivering therapeutic agents by administering compositions including a bacterial collagen-binding polypeptide segment linked to the therapeutic agent to subjects in need of treatment with the therapeutic agent are provided. In these methods, the therapeutic agent is not a PTH/PTHrP receptor agonist or antagonist, basic fibroblast growth factor (bFGF) or epidermal growth factor (EGF). The bacterial collagen-binding polypeptide segment delivers the agent to sites of partially untwisted or under-twisted collagen. Methods of treating collagenopathies using a composition including a collagen-binding polypeptide and a PTH/PTHrP receptor agonist are also provided. In addition, methods of treating hyperparathyroidism, and hair loss using compositions comprising a collagen binding polypeptide and a PTH/PTHrP receptor agonist are provided. Finally, methods of reducing hair regrowth by administering a composition including a collagen binding polypeptide and a PTH/PTHrP receptor antagonist are provided.

Department

Chemistry and Biochemistry

Patent Number

US9579273

Application Number

US 20140377215 A1

Application Published

12-25-2014

Application Filed

12-14-2012

Assignee

The Kitasato Institute (JP); National University Corporation Kagawa University (JP); Montefiore Medical Center (New York, NY); The Board of Trustees of the University of Arkansas (Little Rock, AR)

Comments

STATEMENT REGARDING FEDERALLY SPONSORED RESEARCH This invention was made with United States government support awarded by the National Institutes of Health grant number NCRR COBRE 8P30GM103450 and INBRE GM103429. The United States may have certain rights in this invention.

Joshua Sakon, Department of Chemistry and Biochemistry

Share

COinS